Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets
- 12 February 2008
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 580 (3) , 285-290
- https://doi.org/10.1016/j.ejphar.2007.11.009
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Src family kinase–mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human plateletsBlood, 2005
- MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent AdvancesAnnual Review of Immunology, 2005
- Platelet Receptors for Adenine Nucleotides and Thromboxane A2Seminars in Thrombosis and Hemostasis, 2004
- Differential Role of Protein Kinase Cδ Isoform in Agonist-induced Dense Granule Secretion in Human PlateletsPublished by Elsevier ,2004
- Platelet-collagen interaction: is GPVI the central receptor?Blood, 2003
- A PLCγ2‐independent platelet collagen aggregation requiring functional association of GPVI and integrin α2β1FEBS Letters, 2003
- Phosphoinositide 3-kinase modulation of β3-integrin represents an endogenous “braking” mechanism during neutrophil transmatrix migrationBlood, 2001
- Platelet–collagen interactions: membrane receptors and intracellular signalling pathwaysEuropean Journal of Clinical Investigation, 1999
- Piceatannol, a Stilbene Phytochemical, Inhibits Mitochondrial F0F1-ATPase Activity by Targeting the F1 ComplexBiochemical and Biophysical Research Communications, 1999
- Thromboxanes: Synthase and receptorsJournal of Biomedical Science, 1998